Cyclo Therapeutics, Inc.
CYTHDelisted Mar 26, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000922247
Cyclo Therapeutics, Inc. was delisted on Mar 26, 2025; its insiders filed their last Form 4 on Mar 3, 2025; 22 institutions reported holding it in 13F filings for Q4 2024, worth $1.33M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Cyclo Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 16 | 14 | −2 |
| Shares | 976.3K | 456.4K | −520.0K (−53.3%) |
| Value | $820.2K | $725.2K | −$95.0K (−11.6%) |
New holders (2)
Institutions that held Cyclo Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 17,800 | $28.0K | 0.00% |
| Northern Trust Corp | 16,593 | $26.4K | 0.00% |
Sold out (4)
Institutions that held Cyclo Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Armistice Capital, LLC | 603,000 | $506.6K |
| UBS Group AG | 1,640 | $1.38K |
| Clear Street Markets LLC | 1,725 | $1.00K |
| FMR LLC | 300 | $252 |